1563MO CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity
Autor: | Obermannova, R., Demlova, R., Selingerova, I., Doubek, M., Okrouhlicova, D., Mlnarikova, M., Pilatova, K., Nevrlka, J., Lejdarova, H., Weinbergerova, B., Cermakova, Z., Valik, D., Mayer, J., Kiss, I., Zdrazilova-Dubska, L. |
---|---|
Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S1131-S1131 |
Databáze: | ScienceDirect |
Externí odkaz: |